Skip to main content
SpringerLink
Log in

NDRG1 Controls Gastric Cancer Migration and Invasion through Regulating MMP-9

  • Original Article
  • Published:
Pathology & Oncology Research

Abstract

The purpose of this study is to detect the clinical significance of NDRG1 and its relationship with MMP-9 in gastric cancer metastatic progression. 101 cases of gastric cancer specimens were utilized to identify the protein expression of NDRG1 and MMP-9 by immunohistochemistry, their clinical significance was also analyzed. The suppression by siRNA-NDRG1 was employed to detect the role of NDRG1 in gastric cancer progression and its relationship with MMP-9. NDRG1 expression was correlated inversely with the degree of tumor cell differentiation (p < 0.01), invasion depth (p < 0.05), lymph node metastasis (p < 0.05) and TNM stage (p < 0.05), whereas MMP-9 was positive correlated with the degree of tumor cell differentiation (p < 0.01), lymph node metastasis (p < 0.05) and TNM stage (p < 0.05), but not correlated with invasion depth (p>0.05). Furthermore, cell proliferation and invasion effect were remarkably enhanced when NDRG1 was silencing, but MMP-9 expression was increased. NDRG1 silencing enhances gastric cancer cells progression through upregulating MMP-9. It suggests that NDRG1 may inhibit the metastasis of gastric cancer via regulating MMP-9.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig 1
Fig 2
Fig 3

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90

    Article  PubMed  Google Scholar 

  2. Melotte V, Qu X, Ongenaert M, van Criekinge W, de Bruïne AP, Baldwin HS, van Engeland M (2010) The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications. FASEB J 24:4153–4166

    Article  CAS  PubMed  Google Scholar 

  3. Matsugaki T, Zenmyo M, Hiraoka K, Fukushima N, Shoda T, Komiya S, Ono M, Kuwano M, Nagata K (2010) N-myc downstream-regulated gene1/Cap43 expression promotes cell differentiation of human osteosarcoma cells. Oncol Rep 24:721–725

    CAS  PubMed  Google Scholar 

  4. Fotovati A, Abu-Ali S, Sugita Y, Nakamura Y (2011) Expression of N-myc downstream regulated gene 1(NDRG1) in central neurocytoma. J Clin Neurosci 18:1383–1385

    Article  CAS  PubMed  Google Scholar 

  5. Maruyama Y, Ono M, Kawahara A, Yokoyama T, Basaki Y, Kage M, Aoyagi S, Kinoshita H, Kuwano M (2006) Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Cancer Res 66:6233–6242

    Article  CAS  PubMed  Google Scholar 

  6. Song Y, Oda Y, Hori M, Kuroiwa K, Ono M, Hosoi F, Basaki Y, Tokunaga S, Kuwano M, Naito S, Tsuneyoshi M (2010) N-myc downstream regulated gene-1∕Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin. Hum Pathol 41:214–222

    Article  CAS  PubMed  Google Scholar 

  7. Akiba J, Murakami Y, Noda M, Watari K, Ogasawara S, Yoshida T, Kawahara A, Sanada S, Yasumoto M, Yamaguchi R, Kage M, Kuwano M, Ono M, Yano H (2011) N-myc downstream regulated gene 1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phase. Cancer Lett 310(1):25–34

    Article  CAS  PubMed  Google Scholar 

  8. Stein S, Thomas EK, Herzog B, Westfall MD, Rocheleau JV, Jackson RS 2nd, Wang M, Liang P (2004) NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem 279:48930–48940

    Article  CAS  PubMed  Google Scholar 

  9. Lerner A, Grafi-Cohen M, Napso T, Azzam N, Fares F (2012) The indolic diet-derivative, 3′3-diindolylmethane induced apoptosis in human colon cancer cells through upregulation of NDRG1. J Biomed Biotechnol 2012:256178

    Article  CAS  PubMed  Google Scholar 

  10. Chen Z, Zhang D, Yue F, Zheng M, Kovacevic Z, Richardson DR (2012) The iron chelators Dp44mT and DFO inhibit TGF-β-induced epithelial-mesenchymal transition via up-regulation of N-myc downstream-regulated gene 1 (NDRG1). J Biol Chem 287:17016–17028

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Richardson A, Kovacevic Z, Richardson DR (2013) Iron chelation: inhibition of key signaling pathways in the induction of the epithelial mesenchymal transition in pancreatic cancer and other tumors. Crit Rev Oncog 18(5):409–434

    Article  PubMed  Google Scholar 

  12. Frank B, Hoffmeister M, Klopp N, Illig T, Chang-Claude J, Brenner H (2010) Single nucleotide polymorphisms in Wnt signaling and cell death pathway genes and susceptibility to colorectal cancer. Carcinogenesis 31:1381–1386

    Article  CAS  PubMed  Google Scholar 

  13. Liu W, Xing F, Iiizumi-Gairani M, Okuda H, Watabe M, Pai SK, Pandey PR, Hirota S, Kobayashi A, Mo YY, Fukuda K, Li Y, Watabe K (2012) N-myc downstream regulated gene 1 modulates Wnt-β-catenin signaling and pleiotropically suppresses metastasis. EMBO Mol Med 4:93–108

    Article  PubMed  PubMed Central  Google Scholar 

  14. Sun J, Zhang D, Zheng Y, Zhao Q, Zheng M, Kovacevic Z, Richardson DR (2013) Targeting the metastasis suppressor, NDRG1, using novel iron chelators: regulation of stress fiber-mediated tumor cell migration via modulation of the ROCK1/pMLC2 signaling pathway. Mol Pharmacol 83(2):454–469

    Article  CAS  PubMed  Google Scholar 

  15. Kachhap SK, Faith D, Qian DZ, Shabbeer S, Galloway NL, Pili R, Denmeade SR, DeMarzo AM, Carducci MA (2007) The N-myc down regulated Gene1(NDRG1) is a Rab4a effector involved in vesicular recycling of E-cadherin. PLoS One 2:e844

    Article  PubMed  PubMed Central  Google Scholar 

  16. Liu YL, Bai WT, Luo W, Zhang DX, Yan Y, Xu ZK, Zhang FL (2011) Downregulation of NDRG1 promotes invasion of human gastric cancer AGS cells through MMP-2. Tumour Biol 32:99–105

    Article  PubMed  Google Scholar 

  17. Tandon A, Sinha S (2011) Structural insights into the binding of MMP9 inhibitors. Bioinformation 5(8):310–314

    Article  PubMed  PubMed Central  Google Scholar 

  18. Liu Z, Li L, Yang Z, Luo W, Li X, Yang H, Yao K, Wu B, Fang W (2010) Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma. BMC Cancer 10:270

    Article  PubMed  PubMed Central  Google Scholar 

  19. Cheng J, Xie HY, Xu X, Wu J, Wei X, Su R, Zhang W, Lv Z, Zheng S, Zhou L (2011) NDRG1 as a biomarker for metastasis, recurrence and poor prognosis in hepatocellular carcinoma. Cancer Lett 310(1):35–45

    Article  CAS  PubMed  Google Scholar 

  20. Sun B, Chu D, Li W, Chu X, Li Y, Wei D, Li H (2009) Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients. J Neuro-Oncol 94(2):213–219

    Article  CAS  Google Scholar 

  21. Al-Nasiry S, Geusens N, Hanssens M, Luyten C, Pijnenborg R (2007) The use of Alamar blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum Reprod 22(5):1304–1309

    Article  CAS  PubMed  Google Scholar 

  22. Chung LC, Tsui KH, Feng TH, Lee SL, Chang PL, Juang HH (2012) L-Mimosine block cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells. Am J Phys Cell Phys 302(4):C676–C685

    Article  CAS  Google Scholar 

  23. Lai LC, Su YY, Chen KC, Tsai MH, Sher YP, Lu TP, Lee CY, Chuang EY (2011) Down-regulation of NDRG1 promotes migration of cancer cells during Reoxygenation. PLoS One 6:e24375

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Lane DJ, Saletta F, Suryo Rahmanto Y, Kovacevic Z, Richardson DR (2013) N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion. PLoS One 8(2):e57273

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Kovacevic Z, Sivagurunathan S, Mangs H, Chikhani S, Zhang D, Richardson DR (2011) The metastasis suppressor, N-myc downstream regulated gene 1(NDRG1), upregulates p21 via p53-independent mechanisms. Carcinogenesis 32(5):732–740

    Article  CAS  PubMed  Google Scholar 

  26. Li S, Chen J, Yang Z, Lu G, Tang H, Hu H (2008) N-myc downstream-regulated gene 1 as a downregulated target gene of PTEN in the controlling of tumourigenesis in endometrioid carcinoma. Indian J Med Res 127:453–459

    PubMed  Google Scholar 

  27. Zhang J, Chen S, Zhang W, Zhang J, Liu X, Shi H, Che H, Wang W, Li F, Yao L (2008) Human differentiation-related gene NDRG1 is a myc downstream-regulated gene that is repressed by myc on the core promoter region. Gene 417:5–12

    Article  CAS  PubMed  Google Scholar 

  28. Sugiki T, Taketomi Y, Kikuchi-Yanoshita R, Murakami M, Kudo I (2004) Association of N-myc downregulated gene1 with heat-shock cognate protein 70 in mast cells. Biol Pharm Bull 27:628–633

    Article  CAS  PubMed  Google Scholar 

  29. VM B, Medová M, Keogh A, Furer C, Zimmer Y, Candinas D, Stroka D (2009) Hsp90 transcriptionally and post-translationally regulates the expression of NDRG1 and maintains the stability of modifying kinase GSK3beta. Biochim Biophys Acta 1793:1597–1603

    Article  Google Scholar 

  30. Lv XH, Chen JW, Zhao G, Feng ZZ, Yang DH, Sun WW, Fan JS, Zhu GH (2012) N-myc downstream-regulated gene 1/Cap43 may function as tumor suppressor in endometrial cancer. J Cancer Res Clin Oncol 138(10):1703–1715

    Article  CAS  PubMed  Google Scholar 

  31. Matsushita K, Uchida K, Saigusa S, Ide S, Hashimoto K, Koike Y, Otake K, Inoue M, Tanaka K, Kusunoki M (2013) Low NDRG1 mRNA expression predicts a poor prognosis in neuroblastoma patients. Pediatr Surg Int 29(4):363–368

    Article  PubMed  Google Scholar 

  32. Wang B, Li J, Ye Z, Li Z, Wu X (2014) N-myc downstream regulated gene 1 acts as a tumor suppressor in ovarian cancer. Oncol Rep 31(5):2279–2285

    CAS  PubMed  Google Scholar 

  33. Mao Z, Sun J, Feng B, Ma J, Zang L, Dong F, Zhang D, Zheng M (2013) The metastasis suppressor, N-myc downregulated gene 1(NDRG1), is a prognostic biomarker for human colorectal cacner. PLoS One 8(7):e68206

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Wang D, Tian X, Jiang Y (2012) NDRG1/Cap43 overexpression in tumor tissues and serum from lung cancer patients. J Cancer Res Clin Oncol 138(11):1813–1820

    Article  CAS  PubMed  Google Scholar 

  35. Nagai MA, Gerhard R, Fregnani JH, Nonogaki S, Rierger RB, Netto MM, Soares FA (2011) Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients. Breast Cancer Res Treat 126:1–14

    Article  CAS  PubMed  Google Scholar 

  36. Chang X, Zhang S, Ma J, Li Z, Zhi Y, Chen J, Lu Y, Dai D (2013) Association of NDRG1 gene promoter methylation with reduced NDRG1 expression in gastric cancer cells and tissue specimens. Cell Biochem Biophys 66(1):93–101

    Article  CAS  PubMed  Google Scholar 

  37. Chang X, Xu X, Ma J, Xue X, Li Z, Deng P, Zhang S, Zhi Y, Chen J, Dai D (2014) NDRG1 expression is related to the progression and prognosis of gastric cancer patients through modulating proliferation, invasion and cell cycle of gastric cancer cells. Mol Biol Rep 41(9):6215–6223

    Article  CAS  PubMed  Google Scholar 

  38. Kawahara A, Akiba J, Hattori S, Yamaguchi T, Abe H, Taira T, Ureshino H, Murakami Y, Watari K, Koufuji K, Shirouzu K, Kuwano M, Ono M, Kage M (2011) Nuclear expression of N-myc downstream regulated gene 1/Ca(2+)-associated protein 43 is closely correlated with tumor angiogenesis and poor survival in patients with gastric cancer. Exp Ther Med 2(3):471–479

    PubMed  PubMed Central  Google Scholar 

  39. Jiang K, Shen Z, Ye Y, Yang X, Wang S (2010) A novel molecular marker for early detection and evaluating prognosis of gastric cancer: N-myc downstream regulated gene-1 (NDRG1). Scand J Gastroenterol 45(7–8):898–908

    Article  CAS  PubMed  Google Scholar 

  40. Carroll J, Field D, O’Connor PM, Cotter PD, Coffey A, Hill C, Ross RP, O’Mahony J (2010) Gene encoded antimicrobial peptides, a template for the design of novel anti-mycobacterial drugs. Bioeng Bugs 1:408–412

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This work was supported in part by a grant from the National Natural Science Foundation of China (#30572162), Higher Specialized Research Fund for Doctoral Program of Ministry of Education of China (#20102104110001) and the Natural Science Foundation of Hebei Province (#H2015206344). The authors would like to thank Institute of General Surgery of China Medical University for supports.

Authors’ Contributions

Xiaojing Chang carried out the molecular genetic studies and drafted the manuscript. Xiaoyang Xu carried out the Western blotting. Jinguo Ma participated in the sequence alignment. Zhenhua Li carried out the IHC, Peng Deng and Jing Chen participated in Cell culture and transfection. Shuanglong Zhang carried out the Alamar Blue. Xiaoying Xue and Yu Zhi participated in the design of the study and performed the statistical analysis. Dongqiu Dai participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.

Author information

Authors and Affiliations

  1. Department of Gastrointestinal Surgery, The Fourth Affiliated Hospital, China Medical University, Shenyang, China

    Xiaojing Chang, Jing Chen & Dongqiu Dai

  2. Cancer Center, The Fourth Affiliated Hospital, China Medical University, Shenyang, China

    Xiaojing Chang, Xiaoyang Xu, Jinguo Ma, Zhenhua Li, Peng Deng, Shuanglong Zhang, Yu Zhi & Dongqiu Dai

  3. Department of Radiotherapy, The Second Hospital, Hebei Medical University, Shijiazhuang, China

    Xiaojing Chang & Xiaoying Xue

  4. Department of Gastrointestinal Surgery and Cancer Center, The Fourth Affiliated Hospital, China Medical University, Shenyang, 110032, China

    Dongqiu Dai

Authors
  1. Xiaojing Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiaoyang Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaoying Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jinguo Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhenhua Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Peng Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jing Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shuanglong Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yu Zhi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Dongqiu Dai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dongqiu Dai.

Ethics declarations

Competing Interests

No conflicts of interest are declared by the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chang, X., Xu, X., Xue, X. et al. NDRG1 Controls Gastric Cancer Migration and Invasion through Regulating MMP-9. Pathol. Oncol. Res. 22, 789–796 (2016). https://doi.org/10.1007/s12253-016-0071-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-016-0071-8

Keywords

Search

Navigation